APA (7th ed.) Citation

OJA, F., IT, S., RSA, G., GM, C., FJF, J., GJ, C., . . . TE, B. (2025). Treatment with checkpoint inhibitors for unresectable non-metastatic mismatch repair deficient intestinal cancer; a case series. BJC reports, 3(1), 67. https://doi.org/10.1038/s44276-025-00171-0

Chicago Style (17th ed.) Citation

OJA, Figaroa, Spaanderman IT, Goedegebuure RSA, Cirkel GM, Jeurissen FJF, Creemers GJ, Bins AD, Tuynman J, and Buffart TE. "Treatment with Checkpoint Inhibitors for Unresectable Non-metastatic Mismatch Repair Deficient Intestinal Cancer; a Case Series." BJC Reports 3, no. 1 (2025): 67. https://doi.org/10.1038/s44276-025-00171-0.

MLA (9th ed.) Citation

OJA, Figaroa, et al. "Treatment with Checkpoint Inhibitors for Unresectable Non-metastatic Mismatch Repair Deficient Intestinal Cancer; a Case Series." BJC Reports, vol. 3, no. 1, 2025, p. 67, https://doi.org/10.1038/s44276-025-00171-0.